Cargando…
HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
HLA-G is an HLA-class Ib molecule that is involved in the establishment of tolerance at the maternal/fetal interface during pregnancy. The expression of HLA-G is highly restricted in adults, but the de novo expression of this molecule may be observed in different hematological and solid tumors and i...
Autores principales: | Morandi, Fabio, Airoldi, Irma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948858/ https://www.ncbi.nlm.nih.gov/pubmed/35328349 http://dx.doi.org/10.3390/ijms23062925 |
Ejemplares similares
-
Immune Checkpoints in Pediatric Solid Tumors: Targetable Pathways for Advanced Therapeutic Purposes
por: Cocco, Claudia, et al.
Publicado: (2021) -
Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
por: Morandi, Fabio, et al.
Publicado: (2020) -
IL-27 Driven Upregulation of Surface HLA-E Expression on Monocytes Inhibits IFN-γ Release by Autologous NK Cells
por: Morandi, Fabio, et al.
Publicado: (2014) -
Structural Modeling and Molecular Dynamics of the Immune Checkpoint Molecule HLA-G
por: Arns, Thais, et al.
Publicado: (2020) -
Future Prospects of Immunotherapy in Non-Small-Cell Lung Cancer Patients: Is There Hope in Other Immune Checkpoints Targeting Molecules?
por: Krzyżanowska, Natalia, et al.
Publicado: (2022)